{
    "Trade/Device Name(s)": [
        "LabonaCheck\u2122M Alc",
        "LabonaCheckTM Alc",
        "LabonaCheckTM AIc HbAlc analyzer",
        "LabonaCheck\u2122m Alc HbA1c Test kit"
    ],
    "Submitter Information": "CERAGEM Medisys Inc.",
    "510(k) Number": "K111128",
    "Predicate Device Reference 510(k) Number(s)": [
        "K993131"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCP"
    ],
    "Summary Letter Date": "September 4, 2012",
    "Summary Letter Received Date": "September 10, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 864.7470"
    ],
    "Regulation Name(s)": [
        "Quantitative, Hemoglobin A1c Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glycated hemoglobin (HbA1c)"
    ],
    "Specimen Type(s)": [
        "Venous whole blood",
        "Capillary fingerstick blood"
    ],
    "Specimen Container(s)": [
        "K3EDTA tube",
        "Sodium heparin tube",
        "NaF tube"
    ],
    "Instrument(s)/Platform(s)": [
        "LabonaCheckTM AIc HbAlc analyzer (MH 200)"
    ],
    "Method(s)/Technology(ies)": [
        "Boronate affinity assay",
        "Spectral reflectance measurement"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Test kit"
    ],
    "Document Summary": "FDA 510(k) summary for LabonaCheck\u2122M Alc system for quantitative measurement of glycated hemoglobin (HbA1c) in venous and capillary blood using boronate affinity assay",
    "Indications for Use Summary": "Quantitative measurement of glycated hemoglobin in venous whole blood and capillary fingerstick samples to monitor long-term glucose control in individuals with diabetes mellitus; intended for multiple patient, professional use",
    "fda_folder": "Hematology"
}